GeneDx Holdings Corp. (WGS)
GeneDx Holdings Market Cap: 3.700B for Dec. 30, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Illumina, Inc. | 20.28B |
| Labcorp Holdings, Inc. | 20.98B |
| Quest Diagnostics, Inc. | 19.52B |
| Guardant Health, Inc. | 13.07B |
| Delcath Systems, Inc. | 358.43M |
Market Cap Related Metrics
| PE Ratio | 2122.72 |
| PS Ratio | 9.127 |
| Price to Book Value | 12.66 |
| Price to Free Cash Flow | 237.35 |
| Price | 128.00 |
| Earnings Yield | 0.05% |
| Operating PE Ratio | 333.26 |
| Normalized PE Ratio | 657.76 |